DE602007013282D1 - Monoklonale antikörper gegen den humanen anti-müllerian-hormonrezeptor vom typ ii (amhr-ii) - Google Patents

Monoklonale antikörper gegen den humanen anti-müllerian-hormonrezeptor vom typ ii (amhr-ii)

Info

Publication number
DE602007013282D1
DE602007013282D1 DE602007013282T DE602007013282T DE602007013282D1 DE 602007013282 D1 DE602007013282 D1 DE 602007013282D1 DE 602007013282 T DE602007013282 T DE 602007013282T DE 602007013282 T DE602007013282 T DE 602007013282T DE 602007013282 D1 DE602007013282 D1 DE 602007013282D1
Authority
DE
Germany
Prior art keywords
amhr
monoclonal antibodies
hormone receptor
human type
müllerian hormone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007013282T
Other languages
English (en)
Inventor
Isabelle Teulon
Andre Pelegrin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Publication of DE602007013282D1 publication Critical patent/DE602007013282D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Reproductive Health (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE602007013282T 2006-11-02 2007-10-31 Monoklonale antikörper gegen den humanen anti-müllerian-hormonrezeptor vom typ ii (amhr-ii) Active DE602007013282D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06291703A EP1918304A1 (de) 2006-11-02 2006-11-02 Monoklonale Antikörper gegen den humanen anti-Müller-Hormon Typ II Rezeptor (AMHR-II)
PCT/IB2007/003301 WO2008053330A2 (en) 2006-11-02 2007-10-31 Monoclonal antibodies against the human anti-mullerian hormone type ii receptor (amhr-ii)

Publications (1)

Publication Number Publication Date
DE602007013282D1 true DE602007013282D1 (de) 2011-04-28

Family

ID=37763855

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007013282T Active DE602007013282D1 (de) 2006-11-02 2007-10-31 Monoklonale antikörper gegen den humanen anti-müllerian-hormonrezeptor vom typ ii (amhr-ii)

Country Status (12)

Country Link
US (2) US8278423B2 (de)
EP (2) EP1918304A1 (de)
JP (3) JP2010508810A (de)
KR (2) KR101686000B1 (de)
CN (2) CN103396491A (de)
AT (1) ATE502052T1 (de)
CA (1) CA2667970C (de)
DE (1) DE602007013282D1 (de)
DK (1) DK2097453T3 (de)
ES (1) ES2363732T3 (de)
PL (1) PL2097453T3 (de)
WO (1) WO2008053330A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1918304A1 (de) * 2006-11-02 2008-05-07 Institut National De La Sante Et De La Recherche Medicale (Inserm) Monoklonale Antikörper gegen den humanen anti-Müller-Hormon Typ II Rezeptor (AMHR-II)
JP5565723B2 (ja) * 2009-04-07 2014-08-06 学校法人北里研究所 抗ｄｃｄモノクローナル抗体
WO2011045202A1 (en) * 2009-10-12 2011-04-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Selective antagonist or agonist of amhrii for modulating fertility
FR2959994B1 (fr) 2010-05-12 2012-08-24 Lfb Biotechnologies Nouveaux anticorps humanises 12g4 mutes et leurs fragments diriges contre le recepteur humain de l'hormone anti-mullerienne de type ii
WO2012166712A1 (en) * 2011-05-27 2012-12-06 Fox Chase Cancer Center Rationally-designed anti-mullerian inhibiting substance type ii receptor antibodies
FR2984750B1 (fr) * 2011-12-23 2014-01-10 Lfb Biotechnologies Nouvelles compositions pharmaceutiques comprenant un anticorps liant le recepteur humain de l'hormone anti-mullerienne de type ii
ITRM20130455A1 (it) * 2013-08-05 2015-02-06 Alfonso Baldi Ligandi dell'ormone anti-mulleriano
CN104865391B (zh) * 2015-05-06 2016-06-22 薛金锋 人抗苗勒激素的酶联免疫检测试剂
WO2017025458A1 (en) * 2015-08-07 2017-02-16 Gamamabs Pharma Antibodies, antibody drug conjugates and methods of use
CA3005025A1 (en) * 2015-09-02 2017-03-09 The Cleveland Clinic Foundation Ovarian cancer vaccines
US10851159B2 (en) * 2016-06-02 2020-12-01 Bloom Diagnostics Ag Antibodies that bind to human anti-Müllerian hormone (AMH) and their uses
US20190270822A1 (en) * 2016-07-26 2019-09-05 Trustees Of Tufts College Antibody-conjugated nanoparticles and medical uses thereof
FR3060394B1 (fr) 2016-12-16 2019-05-24 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Combinaison d'anticorps anti-cd303 et anti-amhrii
BR112019021495A8 (pt) * 2017-04-14 2023-05-02 Inst Curie Compostos de ligação ao amhrii para prevenção ou tratamento de cânceres de pulmão
CN110891970B (zh) * 2017-04-14 2024-05-10 埃克塞里艾克西斯公司 用于预防或治疗癌症的amhrii结合化合物
CN110531077B (zh) * 2018-05-25 2023-07-07 荣昌生物制药(烟台)股份有限公司 间皮素免疫组化检测试剂盒
CN113423732A (zh) * 2018-09-05 2021-09-21 德克萨斯大学系统董事会 针对endotrophin的单克隆抗体及其用途
WO2020186158A2 (en) * 2019-03-13 2020-09-17 Ulmert Hans David Staffan Prame binding molecules and uses thereof
EP3789401A1 (de) 2019-09-03 2021-03-10 Gamamabs Pharma Amhrii-bindende antikörperarzneimittelkonjugate und deren verwendung bei der behandlung von krebserkrankungen
CN114450304B (zh) * 2019-09-27 2023-12-12 国家医疗保健研究所 抗苗勒管抑制物质抗体及其用途
EP3812008A1 (de) * 2019-10-23 2021-04-28 Gamamabs Pharma Amh-kompetitiver antagonistischer antikörper
CN112251444B (zh) * 2020-10-21 2023-05-16 恺佧生物科技(上海)有限公司 一种改造的amh基因序列及利用其制备amh的方法
WO2022170219A1 (en) 2021-02-05 2022-08-11 Iovance Biotherapeutics, Inc. Adjuvant therapy for cancer
CN113238057B (zh) * 2021-04-23 2022-10-14 迪瑞医疗科技股份有限公司 苗勒氏管抑制物受体化学发光免疫检测试剂盒及其制备方法
KR20240099253A (ko) * 2021-10-08 2024-06-28 라노바 메디신즈 디벨롭먼트 컴퍼니 리미티드 항-amhrii 항체

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2807767B1 (fr) * 2000-04-12 2005-01-14 Lab Francais Du Fractionnement Anticorps monoclonaux anti-d
CA2441863A1 (en) * 2001-03-29 2002-10-10 Kenya Shitara Drugs containing genetically modified antibody against ganglioside gd3
US7425328B2 (en) 2003-04-22 2008-09-16 Purdue Pharma L.P. Tissue factor antibodies and uses thereof
WO2005005615A2 (en) * 2003-07-08 2005-01-20 Fox Chase Cancer Center Anti-mullerian inhibiting substance type ii receptor (misiir) immunoconjugates to detect and treat cancer
EP1918304A1 (de) * 2006-11-02 2008-05-07 Institut National De La Sante Et De La Recherche Medicale (Inserm) Monoklonale Antikörper gegen den humanen anti-Müller-Hormon Typ II Rezeptor (AMHR-II)
JP2013212800A (ja) * 2012-04-03 2013-10-17 Webasto Japan Kk サンルーフのウエザーストリップ構造及びウエザーストリップの取付方法

Also Published As

Publication number Publication date
PL2097453T3 (pl) 2011-09-30
WO2008053330A3 (en) 2008-10-23
US20130164300A1 (en) 2013-06-27
WO2008053330A2 (en) 2008-05-08
CN101573382A (zh) 2009-11-04
DK2097453T3 (da) 2011-06-27
ES2363732T3 (es) 2011-08-12
KR101686000B1 (ko) 2016-12-14
JP2016102109A (ja) 2016-06-02
US20100135996A1 (en) 2010-06-03
ATE502052T1 (de) 2011-04-15
CN103396491A (zh) 2013-11-20
CA2667970A1 (en) 2008-05-08
US8278423B2 (en) 2012-10-02
KR20150036812A (ko) 2015-04-07
EP1918304A1 (de) 2008-05-07
EP2097453A2 (de) 2009-09-09
JP5903717B2 (ja) 2016-04-13
EP2097453B1 (de) 2011-03-16
US9458239B2 (en) 2016-10-04
CN101573382B (zh) 2013-08-21
JP2014076992A (ja) 2014-05-01
KR20090101897A (ko) 2009-09-29
CA2667970C (en) 2016-10-04
JP2010508810A (ja) 2010-03-25

Similar Documents

Publication Publication Date Title
ATE502052T1 (de) Monoklonale antikörper gegen den humanen anti- müllerian-hormonrezeptor vom typ ii (amhr-ii)
NL301089I2 (nl) imlifidase
CY1118369T1 (el) Αντισωματα εναντι cd38 για την θεραπεια πολλαπλου μυελωματος
UA106194C2 (ru) Диагностика и лечение рака с применением антитела к ereg
DK1951759T3 (da) Anti-EGFR-antistoffer
EA201100923A1 (ru) Антитела человека против тканевого фактора
CY1117124T1 (el) ΑΝΘΡΩΠΟΠΟΙΗΜΕΝΟΙ ANTΑΓΩΝΙΣΤΕΣ ΑΝΤΙ-β7 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΩΝ
NO20074563L (no) Novel anti-plgf antibody
CY1115572T1 (el) Αντι cxcr4 αντισωματα και χρηση αυτων για τη θεραπεια καρκινου
EP2103628A4 (de) Monoklonaler anti-claudin-3-antikörper und die behandlung und diagnose von krebs unter dessen verwendung
ATE469895T1 (de) Cgrp-rezeptorantagonisten
EA200802182A1 (ru) Модифицированные гуманизированные антитела против интерлейкина-18
WO2006138729A3 (en) Receptor antagonists for treatment of metastatic bone cancer
EA200800355A1 (ru) Нейтрализующие антитела человека против b7rp1
NO20083891L (no) Anti-5T4 antistoffer og anvendelser derav
EA200900767A1 (ru) Антагонистические антитела против ephb3
NO20083895L (no) Anti-IGF-1R human monoklonalantibody formulering
NZ594466A (en) Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies
NO20084546L (no) Diagnostikk og behandlinger for tumorer
GT200900002A (es) Anticuerpo antagonista para el tratamiento del cancer
ATE553778T1 (de) Für humanes hepcidin spezifische antikörper
EA201070636A1 (ru) Ингибирование рецептора белка, стимулирующего макрофаги (ron), и способы его лечения
ATE517920T1 (de) Humanisierte antikörper gegen interferon-alpha- rezeptor-1 (ifnar-1)
ATE497392T1 (de) Therapie mit anti-cd4-antikörpern und bestrahlung
ITMI20031127A1 (it) Anticorpi anti-hgf-r e loro uso